Our 3’UTR technology specifically targets and degrades any transcript of interest

Gallery

Contacts

411 University St, Seattle, USA

[email protected]

347-842-6873
339-368-0125
646-620-8700

Twitter Facebook-f Pinterest-p Instagram

Shop

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
read more...
close-link
Click Me